May 29, 2017 | Hong Kong-based investment group AID Partners has acquired Israeli diagnostics startup GeneSort for $23 million. Founded in 2013, GeneSort is led by Dr. Gil Pogozelich. The molecular diagnostics company is focused on integrating genomics with personalized therapeutic approaches.